ArticleBiomimetics (Basel, Switzerland)2026
A Novel Algebraic Saturation-Based PID Controller Optimized by Animated Oat Algorithm for Ultra-Fast Dynamic Response of Automatic Voltage Regulation.
Article in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhanced Multi-Strategy Improved Animated Oat Optimization Algorithm and Its Engineering Application.Biomimetics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a novel algebraic saturation-based Proportional-Integral-Derivative (ASB-PID) controller for achieving ultra-fast and well-damped dynamic response in automatic voltage regulator (AVR) systems. The proposed controller incorporates an algebraic saturation-based nonlinear transformation applied to both the error signal and its derivative, enabling adaptive control sensitivity across different operating regions. This formulation preserves high sensitivity near the equilibrium point while effectively limiting excessive control action under large transient deviations, thereby overcoming the inherent trade-off between response speed and overshoot observed in conventional PID-based controllers. To address the highly nonlinear and multimodal tuning problem, the controller parameters are optimally determined using the Animated Oat Optimization Algorithm (AOOA), which provides strong global exploration capability and stable convergence behavior. The effectiveness of AOOA is first validated through comparative analysis with widely used metaheuristic algorithms, including Particle Swarm Optimization (PSO), Gray Wolf Optimizer (GWO), Whale Optimization Algorithm (WOA), and Sine Cosine Algorithm (SCA). Furthermore, the proposed controller is benchmarked against recently developed high-performance AVR control strategies, including Gudermannian-PID (G-PID), fractional-order PID (FOPID), and higher-order PID-based controllers. Simulation results demonstrate that the proposed AOOA-optimized ASB-PID controller achieves a rise time of 0.0215 s and a settling time of 0.0383 s with zero overshoot and negligible steady-state error, significantly outperforming both competing optimization algorithms and state-of-the-art control designs. Comprehensive benchmarking further confirms that the proposed method consistently delivers superior performance in terms of speed, stability, and robustness, indicating that it provides an effective, computationally efficient, and scalable solution for high-performance AVR systems and broader nonlinear control applications. Unlike conventional nonlinear PID designs based on hyperbolic or sigmoid mappings, the proposed algebraic formulation provides a more explicit and effective saturation mechanism, enabling a superior balance between transient speed and overshoot suppression without increasing controller complexity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.